Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

<p>Abstract</p> <p>Background</p> <p>Hypofractionated stereotactic body radiation therapy (SBRT) has been advanced as monotherapy for low-risk prostate cancer. We examined the dose distributions and early clinical outcomes using this modality for the treatment of interm...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ju Andrew W, Wang Hongkun, Oermann Eric K, Sherer Benjamin A, Uhm Sunghae, Chen Viola J, Pendharkar Arjun V, Hanscom Heather N, Kim Joy S, Lei Siyuan, Suy Simeng, Lynch John H, Dritschilo Anatoly, Collins Sean P
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMC 2013-01-01
Cyfres:Radiation Oncology
Pynciau:
Stereotactic body radiotherapy
Prostate cancer
SBRT
CyberKnife
Intermediate-risk
Monotherapy
Hypofractionation
Mynediad Ar-lein:http://www.ro-journal.com/content/8/1/30
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg